Editorial: Management of Cardiovascular Risk Factors and Other Comorbidities in Chronic Kidney Disease

Overview

Journal Curr Opin Nephrol Hypertens

Specialties Cardiology & Vascular Diseases
Nephrology

Date 2020 Jul 24

PMID 32701601

Citations 1

Authors

Sehrish Ali

Muhammad S Ajmal

Sankar D Navaneethan

Affiliations

Soon will be listed here.

Citing Articles

The Dual Burden: Exploring Cardiovascular Complications in Chronic Kidney Disease.

Caturano A, Galiero R, Rocco M, Tagliaferri G, Piacevole A, Nilo D Biomolecules. 2024; 14(11).

PMID: 39595570 PMC: 11591570. DOI: 10.3390/biom14111393.

References

Molnar A, Bota S, McArthur E, Lam N, Garg A, Wald R . Risk and complications of venous thromboembolism in dialysis patients. Nephrol Dial Transplant. 2017; 33(5):874-880. DOI: 10.1093/ndt/gfx212. View

Matsushita K, van der Velde M, Astor B, Woodward M, Levey A, de Jong P . Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet. 2010; 375(9731):2073-81. PMC: 3993088. DOI: 10.1016/S0140-6736(10)60674-5. View

Goonasekera M, Mafham M, Haynes R . LDL-cholesterol reduction in chronic kidney disease: options beyond statins. Curr Opin Nephrol Hypertens. 2020; 29(5):480-488. DOI: 10.1097/MNH.0000000000000628. View

Yao X, Tangri N, Gersh B, Sangaralingham L, Shah N, Nath K . Renal Outcomes in Anticoagulated Patients With Atrial Fibrillation. J Am Coll Cardiol. 2017; 70(21):2621-2632. DOI: 10.1016/j.jacc.2017.09.1087. View

Wilkinson T, McAdams-DeMarco M, Bennett P, Wilund K . Advances in exercise therapy in predialysis chronic kidney disease, hemodialysis, peritoneal dialysis, and kidney transplantation. Curr Opin Nephrol Hypertens. 2020; 29(5):471-479. PMC: 7526394. DOI: 10.1097/MNH.0000000000000627. View

Walther C, Richardson P, Virani S, Winkelmayer W, Navaneethan S . Association between intensity of statin therapy and mortality in persons with chronic kidney disease. Nephrol Dial Transplant. 2018; 35(2):312-319. DOI: 10.1093/ndt/gfy237. View

Wei S, Chang Y, Mau L, Lin M, Chiu H, Tsai J . Chronic kidney disease care program improves quality of pre-end-stage renal disease care and reduces medical costs. Nephrology (Carlton). 2010; 15(1):108-15. DOI: 10.1111/j.1440-1797.2009.01154.x. View

Shroff G, Stoecker R, Hart A . Non-Vitamin K-Dependent Oral Anticoagulants for Nonvalvular Atrial Fibrillation in Patients With CKD: Pragmatic Considerations for the Clinician. Am J Kidney Dis. 2018; 72(5):717-727. DOI: 10.1053/j.ajkd.2018.02.360. View

Awan A, Walther C, Richardson P, Shah M, Winkelmayer W, Navaneethan S . Prevalence, correlates and outcomes of absolute and functional iron deficiency anemia in nondialysis-dependent chronic kidney disease. Nephrol Dial Transplant. 2019; 36(1):129-136. DOI: 10.1093/ndt/gfz192. View

10.

MacKinnon H, Wilkinson T, Clarke A, Gould D, OSullivan T, Xenophontos S . The association of physical function and physical activity with all-cause mortality and adverse clinical outcomes in nondialysis chronic kidney disease: a systematic review. Ther Adv Chronic Dis. 2018; 9(11):209-226. PMC: 6196637. DOI: 10.1177/2040622318785575. View

11.

Hedayati S, Gregg L, Carmody T, Jain N, Toups M, Rush A . Effect of Sertraline on Depressive Symptoms in Patients With Chronic Kidney Disease Without Dialysis Dependence: The CAST Randomized Clinical Trial. JAMA. 2017; 318(19):1876-1890. PMC: 5710375. DOI: 10.1001/jama.2017.17131. View

12.

Gregg L, Hedayati S . Pharmacologic and psychological interventions for depression treatment in patients with kidney disease. Curr Opin Nephrol Hypertens. 2020; 29(5):457-464. PMC: 7735461. DOI: 10.1097/MNH.0000000000000629. View

13.

Edmonston D, Sparks M . Therapeutic options for chronic kidney disease-associated pulmonary hypertension. Curr Opin Nephrol Hypertens. 2020; 29(5):497-507. DOI: 10.1097/MNH.0000000000000624. View

14.

Vanden Wyngaert K, Van Craenenbroeck A, Van Biesen W, Dhondt A, Tanghe A, Van Ginckel A . The effects of aerobic exercise on eGFR, blood pressure and VO2peak in patients with chronic kidney disease stages 3-4: A systematic review and meta-analysis. PLoS One. 2018; 13(9):e0203662. PMC: 6133282. DOI: 10.1371/journal.pone.0203662. View

15.

Walther C, Triozzi J, Deswal A . Iron deficiency and iron therapy in heart failure and chronic kidney disease. Curr Opin Nephrol Hypertens. 2020; 29(5):508-514. DOI: 10.1097/MNH.0000000000000630. View

16.

von Haehling S, Ebner N, Evertz R, Ponikowski P, Anker S . Iron Deficiency in Heart Failure: An Overview. JACC Heart Fail. 2018; 7(1):36-46. DOI: 10.1016/j.jchf.2018.07.015. View

17.

Luo Y, Kataoka Y, Ostinelli E, Cipriani A, Furukawa T . National Prescription Patterns of Antidepressants in the Treatment of Adults With Major Depression in the US Between 1996 and 2015: A Population Representative Survey Based Analysis. Front Psychiatry. 2020; 11:35. PMC: 7033625. DOI: 10.3389/fpsyt.2020.00035. View

18.

Mavrakanas T, Charytan D, Winkelmayer W . Direct oral anticoagulants in chronic kidney disease: an update. Curr Opin Nephrol Hypertens. 2020; 29(5):489-496. PMC: 7769201. DOI: 10.1097/MNH.0000000000000634. View

19.

Trachtenberg A, Collister D, Rigatto C . Recent advances in the treatment of uremic pruritus. Curr Opin Nephrol Hypertens. 2020; 29(5):465-470. DOI: 10.1097/MNH.0000000000000625. View

20.

Walther C, Nambi V, Hanania N, Navaneethan S . Diagnosis and Management of Pulmonary Hypertension in Patients With CKD. Am J Kidney Dis. 2020; 75(6):935-945. PMC: 7247937. DOI: 10.1053/j.ajkd.2019.12.005. View